Prevention of perinatal group b streptococcal infection, is it necessary in our country?

Authors

  • Hernán Cortés

DOI:

https://doi.org/10.18597/rcog.531

Keywords:

Streptococcus group B, disease, prophylaxis, colonization

Abstract

Group B Streptococcus or agalactie (GBS) is a habitual saprophytic microorganism of the genitourinary and gastrointestinal tracts of human beings. Vertical transmission from the mother to the fetus, as occurs, favors the development of early onset disease in the neonate. The prevalence of maternal colonization is variable (5-30%) depending on the country, race, age and technique of sampling used for culture. Approximately 40-70% of neonates from mothers who are positive for GBS are colonized and of those, 1 to 2% will develop invasive disease (sepsis, meningitis or pneumonia). Fortunately, most of these infections can be prevented by prophylactic antibiotics during labor and deliver y.

However, in our environment, the impact of this pathology is unknown, and strategies for prevention have not been implemented. Research in our country is needed to address this issue and implement diagnostic and treatment strategies.

Author Biography

Hernán Cortés

Ginecoobstetra, profesor de perinatología, Departamento de Ginecología y Obstetricia. Universidad de Antioquia.

References

Franciosi RA, Knostman JD, Zimmerman RA. Group B streptococcal neonatal and infant infections. J Pediatr 1973;82:707-18.

CDC.prevention of Perinatal group B streptococcal disease: a public health perspective. MMWR Recomm Rep 1996;45:1-24.

Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000;342:15-20.

Gibbs R, Sweet R. Maternal and fetal infectious disorders. En: Creasy R, Resnik R. Maternal-Fetal Medicine. 4ª Ed. Saunders Company. p. 674-77.

Gladstone IM, Ehrenkranz RA, Edberg SC. A ten year review of neonatal sepsis and comparison with the previous fifty year experience. Pediatr Infect Dis J 1990;9:819-25.

Restrepo A, Serna L, Vanegas C, et al. Prevalencia de Streptococcus agalactiae en gestantes con factores de riesgo y sus recién nacidos. Hospital Universitario San Vicente de Paúl. 2002. Infectio 2003;7:147-52.

Trujillo M, Ospina B, Fama M. Reevaluación del estado de colonización por streptococcus del grupo B en madres e hijos al momento del parto. Rev Ces Medicina 1999;13:44.

Gonzalez CP, Gonzalez JE. Prevalencia de Estreptococo beta hemolítico en mujeres embarazadas de alto riesgo en el Hospital Simón Bolívar de Bogotá. UCIN 2001;2:7-15.

Manotas RJ, Baquero D. Frecuencia de aislamiento de Streptococcus agalactiae en un grupo de embarazadas y sus productos. IATREIA 1989;2:111-13.

Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of Perinatal Group B Streptococcal Disease Revised Guidelines from CDC. MMWR Recomm Rep 2002;16;51:1-22.

Schuchat A, Deaver RK, Plikaytis BD, et al. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. Pediatr Infect Dis J 1994;13:623-9.

Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:1665-9.

Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990. MMWR CDC Surveill Summ 1992;41:25-32.

Schrag SJ, Zell RE, Lynfield R, Roome A, Arnold KE, Craig AS, et al. A population based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002;347:233-9.

Gibbs R, Schrag S, Schuchat A. Perinatal infections due to group B streptococci. Obstet Gynecol 2004; 104: 1062-76.

Stoll BJ, Hansen N, Fanaroff A, Wright LL, Carlo WA, Ehrenkranz EA, et al. Changes in pathogens causing early-onset sepsis in very low birth weight infants. N Engl J Med 2002; 347:240-7.

Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999;282:325-6.

Bergeron MG, Ke D, Menard C, et al. Rapid detection of group B streptococci in pregnant women at delivery. N Engl J Med 2000;343:175-9.

How to Cite

1.
Cortés H. Prevention of perinatal group b streptococcal infection, is it necessary in our country?. Rev. colomb. obstet. ginecol. [Internet]. 2005 Sep. 9 [cited 2024 May 17];56(3):231-8. Available from: https://revista.fecolsog.org/index.php/rcog/article/view/531

Downloads

Download data is not yet available.

Published

2005-09-09
QR Code

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo